Bustamante, S
The earliest controlled human evidence for luteolins neuroimmune effects comes from a randomized, double-blind clinical trial that evaluated a complex of PEA-LUT in children with autism spectrum disorder ( A recent double-blind, placebo-controlled crossover trial evaluated the effects of luteolin supplementation (250 mg taken twice daily for 2 weeks) on neurocognitive performance in healthy adults
Baseline and ongoing monitoring: Before initiating GLP-1/GIP therapy, consider measuring baseline B12 levels, particularly in patients concurrently taking metformin, those with previous bariatric surgery, individuals following plant-based diets, or those with malabsorption conditions
and X.H.)
By inhibiting -glucosidase, RES reduces postprandial blood glucose spikes, contributing to improved glycemic control ( in vitro cellular experiment a RES intervention can alleviate insulin resistance (IR) and enhance the activation of AMPK ( RES can exert its anti-diabetic effects through the coordination of four mechanisms: inhibiting glucosidase activity, improving IR, protecting pancreatic -cells, and inhibiting gluconeogenesis via signaling pathways such as PI3K/serinethreonine protein kinase AKT